Evaluating brain blood flow regulation in infants with congenital heart disease
Official title: The Impact of Perioperative Neurovascular Coupling on Outcome in Infants With Congenital Heart Disease.
Run by Universitaire Ziekenhuizen KU Leuven · NCT06190210 · Data updated 2026-11-12
This study looks at how blood flow to the brain works in infants with congenital heart disease to see if it affects their brain development and helps create better follow-up care for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 6 Months |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | April 2, 2025 |
| Trial ID | NCT06190210 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants with congenital heart disease who require a first surgical or percutaneous intervention within the first six months of life.
✕Probably not a fit
Patients who may not benefit from this study include those with syndromes or genetic conditions associated with neurological impairment or those requiring treatment after six months of life.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the relationship between cerebral autoregulation and neurovascular coupling in infants diagnosed with congenital heart disease (CHD). It aims to identify peri-operative physiological risk factors that may affect brain maturation and contribute to neurodevelopmental disorders. By utilizing electroencephalography (EEG) and near-infrared spectroscopy, the study seeks to develop a risk model and guidelines for standardized developmental follow-up in this vulnerable population. The research focuses on infants requiring surgical or percutaneous intervention within their first six months of life.
Why it matters
Potential benefit: If successful, this study could lead to improved monitoring and intervention strategies for infants with congenital heart disease, potentially enhancing their neurodevelopmental outcomes.
How similar studies have gone: While the specific approach of this study may be novel, other studies have explored neurodevelopmental outcomes in infants with congenital heart disease, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * CHD warranting a first percutaneous or surgical intervention in the first 6 months, including but not limited to transposition of the great arteries (TGA), univentricular heart (UVH), Tetralogy of Fallot (TOF), coarctation of the aorta (CoA), total abnormal pulmonary venous drainage (TAPVU), Common arterial trunc (TA), large patent ductus arteriosus (PDA) or VSD and AVSD for which treatment is necessary within the first 6 months of life. * Treatment provided at the University Hospitals Leuven. Exclusion Criteria: * Syndromes or proven genetic conditions which are associated with neurological impairment * CHD warranting treatment after 6 months of life * Suspected or proven metabolic diseases * No parental/guardian consent
Where it's running
-
UZ Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting
Study contacts
- Study coordinator: Liselotte Van Loo, MD
- Email: liselotte.vanloo@uzleuven.be
- Phone: +3216346057
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parent-child yoga to help children with congenital heart disease focus better
This study is testing if parent-child yoga can help children with congenital heart disease focus better and improve their overall well-being.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.